Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BETTER THERAPEUTICS, INC.

(BTTX)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
01/11/2022 01/12/2022 01/13/2022 01/14/2022 01/18/2022 Date
4.77(c) 4.84(c) 4.64(c) 4.6(c) 4.18(c) Last
59 696 42 773 42 413 207 267 78 566 Volume
-1.45% +1.47% -4.13% -0.86% -9.13% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 - - -
Net income 2021 -34,8 M - -
Net cash position 2021 57,0 M - -
P/E ratio 2021 -2,84x
Yield 2021 -
Sales 2022 - - -
Net income 2022 -42,1 M - -
Net Debt 2022 - - -
P/E ratio 2022 -2,69x
Yield 2022 -
Capitalization 98,6 M 98,6 M -
EV / Sales 2021 -
Capi. / Sales 2022 -
Nbr of Employees 40
Free-Float -
More Financials
Company
Better Therapeutics, Inc, formerly Mountain Crest Acquisition Corp II, is engaged in offering prescription digital therapeutics platform for treating cardiometabolic diseases. The Company creates treatments to reverse the progression of disease, improve quality of life, and inform clinical decisions. It builds prescription digital therapeutics that deliver a new kind of behavioral therapy and creating feedback... 
More about the company
All news about BETTER THERAPEUTICS, INC.
01/14BETTER THERAPEUTICS, INC. Changes in Registrant's Certifying Accountant, Financial Sta..
AQ
01/06Better Therapeutics Gives Update on Study of BT-001; Adds Mass General Brigham to Resea..
MT
01/06Better Therapeutics Highlights Recent Progress and Updates Outlook Through Q1 2022
BU
2021LifeSci Capital Starts Better Therapeutics at Outperform With $15 Price Target
MT
2021BETTER THERAPEUTICS, INC.(NASDAQCM : BTTX) added to S&P TMI Index
CI
2021INSIDER BUY : Better Therapeutics
MT
2021INSIDER BUY : Better Therapeutics
MT
2021Better Therapeutics Appoints Deepti Sodhi Jaggi, PharmD, as Chief Strategy Officer
BU
2021Better Therapeutics, Inc. Appoints Deepti Sodhi Jaggi as Chief Strategy Officer
CI
2021BETTER THERAPEUTICS, INC. Financial Statements and Exhibits (form 8-K/A)
AQ
2021BETTER THERAPEUTICS, INC. : Changes in Registrant's Certifying Accountant, Financial State..
AQ
2021Chardan Starts Better Therapeutics at Buy With $17 Price Target
MT
2021BETTER THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION ..
AQ
2021BETTER THERAPEUTICS, INC. : Non-Reliance on Previous Financials, Audits or Interim Review ..
AQ
2021Better Therapeutics Completes Enrollment for Trial of BT-001 to Treat Type 2 Diabetes
MT
More news
News in other languages on BETTER THERAPEUTICS, INC.
01/06Better Therapeutics fait le point sur l'étude du BT-001 et ajoute le Mass General Brigh..
2021ACHATS D'INITIÉS : Better Therapeutics
2021ACHATS D'INITIÉS : Better Therapeutics
2021Better Therapeutics achève le recrutement pour l'essai du BT-001 dans le traitement du ..
More news
Analyst Recommendations on BETTER THERAPEUTICS, INC.
More recommendations
Chart BETTER THERAPEUTICS, INC.
Duration : Period :
Better Therapeutics, Inc. Technical Analysis Chart | BTTX | US08773T1043 | MarketScreener
Technical analysis trends BETTER THERAPEUTICS, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 4
Last Close Price 4,18 $
Average target price 17,67 $
Spread / Average Target 323%
EPS Revisions
Managers and Directors
Kevin J. Appelbaum President & Chief Executive Officer
Mark Heinen Chief Financial Officer & Head-Finance
David P. Perry Executive Chairman
Mark Berman Chief Medical Officer
Richard H. Carmona Independent Director
Sector and Competitors
1st jan.Capi. (M$)
BETTER THERAPEUTICS, INC.-10.11%99
MODERNA, INC.-26.53%75 661
LONZA GROUP AG-15.05%52 427
IQVIA HOLDINGS INC.-14.11%46 293
SEAGEN INC.-15.72%23 824
ICON PUBLIC LIMITED COMPANY-17.86%20 707